A REVIEW OF ADDITIONAL BEN VENUE 483 OBSERVATIONS (5/25/11)  COMMENT  A review of additional Ben Venue Form FDA 483 Observations suggests that many of these observations relate to either not following or following incorrectly the FDA's Guidance for Industry Sterile Drug Products (September 2004).  The Observations that follow include … [Read more...]